主要代表性論文: 1. Shuai-Shuai Ge*, Qiao-Cheng Qiu*, Hai-Ping Dai*, Xiang-Dong Shen*, Tian-Mei Wu, Jia-Hui Du, Chao-Ling Wan, Hong-Jie Shen, De-Pei Wu#, Sheng-Li Xue#, Song-Bai Liu#. Mutation spectrum of FLT3 and significance of non-canonical FLT3 mutations in haematological malignancy. British Journal of Haematology, 2023;202(3):539-549（通訊作者） 2. Junjie Shen*, Derui Yan*, Lu Bai, Ruirui Geng, Xulun Zhao, Huijun Li, Yongfei Dong, Jianping Cao, Zaixiang Tang# and Song-Bai Liu#. An 11-Gene Signature Based on Treatment Responsiveness Predicts Radiation Therapy Survival Benefit Among Breast Cancer Patients. Frontiers in Oncology, 2022;11:816053（通訊作者） 3. Song-Bai Liu*, Hao-Jie Dong*, Xie-Bing Bao*, Qiao-Cheng Qiu*, Hong-Zhi Li, Hong-Jie Shen, Zi-Xuan Ding, Chao Wang, Xiao-Ling Chu, Jing-Qiu Yu, Tao Tao, Zheng Li, Xiao-Wen Tang, Su-Ning Chen, De-Pei Wu#, Ling Li#, Sheng-Li Xue#. Impact of FLT3-ITD length on prognosis of acute myeloid leukemia. Haematologica, 2019;104(1):e9-e12（ 第一作者） 4. Songbai Liu*, Guojun Lv, Shafat Ali, Wenpeng Liu, Li Zheng, Huifang Dai, Hongzhi Li, Hong Xu, Yuejin Hua, Yajing Zhou, Janice Ortega, Guo-Min Li, Thomas A Kunkel, and Binghui Shen#. Okazaki fragment maturation involves α-segment error editing by the mammalian FEN1/MutSαfunctional complex. EMBO J, 2015;34:1829-1843（第一作者） 5. Zhigang Guo*, Julie Kanjanapangka*, Na Liu*, Songbai Liu*, Changwei Liu*, Zhenxing Wu, Yingjie Wang, Tiffany Loh, Claudia Kowolik, JoonasJamsen, Mian Zhou, Khue Truong, Yuan Chen, Li Zheng, and Binghui Shen#. Sequential Posttranslational Modifications Program FEN1 Degradation during Cell-Cycle Progression. Molecular Cell, 2012;47:444–456（共同第一作者） 代表性授權(quán)專利： 1. 劉松柏；湯在祥；陳蘇寧；王璽超；孫昊；東勇飛；一種急性髓系白血病患者銅死亡相關(guān)預(yù)后模型構(gòu)建方法，發(fā)明專利，申請?zhí)枺?/span>202310672840.1，已授權(quán)(2024.1.30) 2. Shengli Xue; Songbai Liu; Shuaishuai Ge; Jiahui Du; Qiaocheng Qiu; Haiping Dai; Jun Wang; Small molecule compound and its application in preparing medicine for treating FLT3 mutant leukemia, Luxembourg(盧森堡) Patent, LU504411, 已授權(quán)(2023.12.5) 3. 薛勝利；劉松柏；邱橋成；葛帥帥；王雋；杜佳慧；戴海萍；一種小分子化合物及其在制備治療 FLT3 突變型白血病藥物中的應(yīng)用，發(fā)明專利，申請?zhí)枺?/span>202310563626.2，已授權(quán)(2023.11.10) 4. 劉松柏；一種檢測PML-RARA融合基因的LAMP引物組、試劑盒及檢測方法，中國發(fā)明專利，申請?zhí)枺?/span>202010873486.5，已授權(quán)(2023.5.24) 5. 劉松柏；一種檢測2019-nCoV的環(huán)介導(dǎo)等溫擴增檢測引物組及其應(yīng)用，中國發(fā)明專利，申請?zhí)枺?/span>202010127615.6.，已授權(quán)(2022.12.23) 6. 劉松柏；常宏；高效藥物篩選的微流控芯片，發(fā)明專利，申請?zhí)枺?/span>202111151239.5，已授權(quán)(2022.9.9) 7. Liu, Songbai; LAMP PRIMER SET, KIT AND DETECTION METHOD FOR DETECTING PML-RARA FUSION GENE, PCT- Luxembourg(盧森堡) Patent, LU500408, 已授權(quán)(2022.1.10) 8. Liu, Songbai; A PRIMER COMBINATION FOR DETECTING 2019NCOV BY LOOP-MEDIATED ISOTHERMAL AMPLIFICATION, PCT- Luxembourg(盧森堡) Patent, LU500205, 已授權(quán)(2021.8.30) 9. 常宏；劉松柏；一種抗HIV的光譜中和抗體，中國發(fā)明專利，專利號：ZL 2020 1 1158187.X，已授權(quán)(2021.6.18) 10. 常宏；劉松柏；一種抗HIV的光譜中和抗體及其制備方法和應(yīng)用，中國發(fā)明專利，專利號：ZL 2020 1 1158169.1，已授權(quán)(2021.4.13) 11. Liu, Songbai; LAMP PRIMER SET, KIT AND DETECTION METHOD FOR DETECTING PML-RARA FUSION GENE, Australian(澳大利亞) Innovation Patent, 2020103158, 已授權(quán)(2020.12.16) 12. Liu, Songbai; A PRIMER COMBINATION FOR DETECTING 2019NCOV BY LOOP-MEDIATED ISOTHERMAL AMPLIFICATION, PCT-Australian(澳大利亞) Innovation Patent, 2020102421, 已授權(quán)(2020.11.4) 13. 劉松柏；杜佳慧；鮑協(xié)炳；一款可定量出液的移液槍，實用新型專利，申請?zhí)枺?/span>2023218012332，已授權(quán)(2023.12.11) 14. 劉松柏；用于可視化核酸恒溫擴增檢測的反應(yīng)容器，實用新型專利，申請?zhí)枺?/span>202222055755.4，已授權(quán)(2022.11.9)，已轉(zhuǎn)讓（2023.7.7） 15. 劉松柏；核酸自動提取裝置，實用新型專利，申請?zhí)枺?/span>202220648006.X，已授權(quán)(2022.9.2) ，已轉(zhuǎn)讓（2023.7.7） 16. 劉松柏；一種具有警示功能的瓊脂糖加熱溶解裝置，實用新型專利，專利號：202022546143.6，已授權(quán)(2021.7.23) 17. 劉松柏；一種便于卸料的瓊脂糖加熱溶解裝置，實用新型專利，專利號：201921111552.4，已授權(quán)(2020.5.26) 18. 胡鶴娟；徐喜林；劉松柏；張雅娟；邱秀芹；王浩??；朱冰影；一種多用圓盤式復(fù)合移液架，實用新型專利，專利號：ZL 2018 2 0306147. 7，已授權(quán)(2018.3.6) |
